1. Landini, N, Orlandi, M, Calistri, L, Nardi, C, Ciet, P, Bellando-Randone, S et al.. Advanced and traditional chest MRI sequence for the clinical assessment of systemic sclerosis related interstitial lung disease, compared to CT: disease extent analysis and correlations with pulmonary function tests. Eur J Radiol. 2023;170 :111239. doi: 10.1016/j.ejrad.2023.111239. PubMed PMID:38056347 .
  2. Nardi, C, Magnini, A, Calistri, L, Cavigli, E, Peired, AJ, Rastrelli, V et al.. Doubts and concerns about COVID-19 uncertainties on imaging data, clinical score, and outcomes. BMC Pulm Med. 2023;23 (1):472. doi: 10.1186/s12890-023-02763-3. PubMed PMID:38007479 PubMed Central PMC10675953.
  3. Matucci-Cerinic, C, Helene, P, Sulaiman, AM, Brogan, PA, Cantarini, L, Gul, A et al.. Validation of the PEDiatric Behçet's Disease classification criteria: an evidence-based approach. Rheumatology (Oxford). 2023; :. doi: 10.1093/rheumatology/kead609. PubMed PMID:37991850 .
  4. Gargani, L, Pugliese, NR, De Biase, N, Mazzola, M, Agoston, G, Arcopinto, M et al.. Exercise Stress Echocardiography of the Right Ventricle and Pulmonary Circulation. J Am Coll Cardiol. 2023;82 (21):1973-1985. doi: 10.1016/j.jacc.2023.09.807. PubMed PMID:37968015 .
  5. De Luca, G, Matucci-Cerinic, M, Mavrogeni, SI. Diagnosis and management of primary heart involvement in systemic sclerosis. Curr Opin Rheumatol. 2024;36 (1):76-93. doi: 10.1097/BOR.0000000000000990. PubMed PMID:37962165 .
  6. Petelytska, L, Bonomi, F, Cannistrà, C, Fiorentini, E, Peretti, S, Torracchi, S et al.. Heterogeneity of determining disease severity, clinical course and outcomes in systemic sclerosis-associated interstitial lung disease: a systematic literature review. RMD Open. 2023;9 (4):. doi: 10.1136/rmdopen-2023-003426. PubMed PMID:37940340 PubMed Central PMC10632935.
  7. Hughes, M, Allanore, Y, Baron, M, Del Galdo, F, Denton, CP, Frech, T et al.. Proton pump inhibitors in systemic sclerosis: a reappraisal to optimise treatment of gastro-oesophageal reflux disease. Lancet Rheumatol. 2022;4 (11):e795-e803. doi: 10.1016/S2665-9913(22)00183-7. PubMed PMID:37936680 PubMed Central PMC10628971.
  8. Natalello, G, Bosello, SL, Campochiaro, C, Abignano, G, De Santis, M, Ferlito, A et al.. Adherence to the Mediterranean Diet in Italian Patients With Systemic Sclerosis: An Epidemiologic Survey. ACR Open Rheumatol. 2023; :. doi: 10.1002/acr2.11627. PubMed PMID:37916477 .
  9. Marongiu, F, Ruberto, MF, Marongiu, S, Matucci Cerinic, M, Barcellona, D. A journey to vasculopathy in systemic sclerosis: focus on haemostasis and thrombosis. Clin Exp Med. 2023; :. doi: 10.1007/s10238-023-01222-x. PubMed PMID:37914967 .
  10. Ferri, C, Raimondo, V, Giuggioli, D, Gragnani, L, Lorini, S, Dagna, L et al.. Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase. J Transl Autoimmun. 2023;7 :100212. doi: 10.1016/j.jtauto.2023.100212. PubMed PMID:37854035 PubMed Central PMC10580042.
  11. Matucci-Cerinic, C, Malattia, C, Pistorio, A, Rosina, S, Consolaro, A, Viola, S et al.. Skin manifestations help identifying different phenotypes of paediatric SAPHO syndrome. Semin Arthritis Rheum. 2023;63 :152277. doi: 10.1016/j.semarthrit.2023.152277. PubMed PMID:37839270 .
  12. Suliman, YA, Campochiaro, C, Hughes, M, Schoones, JW, Giuggioli, D, Moinzadeh, P et al.. Surgical management of digital ulcers in systemic sclerosis: A systematic literature review. Semin Arthritis Rheum. 2023;63 :152266. doi: 10.1016/j.semarthrit.2023.152266. PubMed PMID:37826898 .
  13. Guler, S, Sarbu, AC, Stalder, O, Allanore, Y, Bernardino, V, Distler, J et al.. Phenotyping by persistent inflammation in systemic sclerosis associated interstitial lung disease: a EUSTAR database analysis. Thorax. 2023;78 (12):1188-1196. doi: 10.1136/thorax-2023-220541. PubMed PMID:37798114 .
  14. De Luca, G, Campochiaro, C, Palmisano, A, Bruno, E, Vignale, D, Peretto, G et al.. Myocarditis in anti-synthetase syndrome: clinical features and diagnostic modalities. Rheumatology (Oxford). 2023; :. doi: 10.1093/rheumatology/kead541. PubMed PMID:37796832 .
  15. Campochiaro, C, Suliman, YA, Hughes, M, Schoones, JW, Giuggioli, D, Moinzadeh, P et al.. Non-surgical local treatments of digital ulcers in systemic sclerosis: a systematic literature review. Semin Arthritis Rheum. 2023;63 :152267. doi: 10.1016/j.semarthrit.2023.152267. PubMed PMID:37778090 .
  16. Alten, R, Burmester, GR, Matucci-Cerinic, M, Salmon, JH, Östör, A, Ng, KJ et al.. Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients. Rheumatol Ther. 2023;10 (6):1575-1595. doi: 10.1007/s40744-023-00597-3. PubMed PMID:37755648 PubMed Central PMC10654280.
  17. Lepri, G, Airò, P, Distler, O, Andréasson, K, Braun-Moscovici, Y, Hachulla, E et al.. Systemic sclerosis and primary biliary cholangitis: Longitudinal data to determine the outcomes. J Scleroderma Relat Disord. 2023;8 (3):210-220. doi: 10.1177/23971983231155948. PubMed PMID:37744053 PubMed Central PMC10515998.
  18. Bruni, C, Buch, MH, Djokovic, A, De Luca, G, Dumitru, RB, Giollo, A et al.. Consensus on the assessment of systemic sclerosis-associated primary heart involvement: World Scleroderma Foundation/Heart Failure Association guidance on screening, diagnosis, and follow-up assessment. J Scleroderma Relat Disord. 2023;8 (3):169-182. doi: 10.1177/23971983231163413. PubMed PMID:37744047 PubMed Central PMC10515996.
  19. Campochiaro, C, Matucci-Cerinic, M. Interstitial lung disease in limited cutaneous systemic sclerosis patients: never let your guard down. Rheumatology (Oxford). 2023; :. doi: 10.1093/rheumatology/kead504. PubMed PMID:37738274 .
  20. Boleto, G, Reiseter, S, Hoffmann-Vold, AM, Mirouse, A, Cacoub, P, Matucci-Cerinic, M et al.. The phenotype of mixed connective tissue disease patients having associated interstitial lung disease. Semin Arthritis Rheum. 2023;63 :152258. doi: 10.1016/j.semarthrit.2023.152258. PubMed PMID:37696231 .
  21. Campochiaro, C, Allanore, Y, Braun-Moscovici, Y, Matucci-Cerinic, M, Balbir-Gurman, A. Is cyclophosphamide still the gold standard in early severe rapidly progressive systemic sclerosis?. Autoimmun Rev. 2023; :103439. doi: 10.1016/j.autrev.2023.103439. PubMed PMID:37690478 .
  22. Rosa, I, Romano, E, Fioretto, BS, El Aoufy, K, Bellando-Randone, S, Matucci-Cerinic, M et al.. Lymphatic Endothelial-to-Myofibroblast Transition: A Potential New Mechanism Underlying Skin Fibrosis in Systemic Sclerosis. Cells. 2023;12 (17):. doi: 10.3390/cells12172195. PubMed PMID:37681927 PubMed Central PMC10486460.
  23. Müller-Ladner, U, Dignass, A, Gaffney, K, Jadon, D, Matucci-Cerinic, M, Lobaton, T et al.. The PROPER Study: A 48-Week, Pan-European, Real-World Study of Biosimilar SB5 Following Transition from Reference Adalimumab in Patients with Immune-Mediated Inflammatory Disease. BioDrugs. 2023;37 (6):873-889. doi: 10.1007/s40259-023-00616-3. PubMed PMID:37632666 PubMed Central PMC10581927.
  24. De Luca, G, Campochiaro, C, Peretto, G, Busnardo, E, Matucci-Cerinic, M, Dagna, L et al.. Cardiac involvement, a threatening very early manifestation of systemic sclerosis: evidence from VEDOSS patients. Clin Exp Rheumatol. 2023;41 (8):1723-1724. doi: 10.55563/clinexprheumatol/vxx4q7. PubMed PMID:37534954 .
  25. Colic, J, Campochiaro, C, Hughes, M, Matucci Cerinic, M, Dagna, L. Investigational drugs for the treatment of scleroderma: what's new?. Expert Opin Investig Drugs. 2023;32 (7):601-614. doi: 10.1080/13543784.2023.2242762. PubMed PMID:37526079 .
  26. Tomelleri, A, Benanti, G, Cariddi, A, Calvisi, SL, Baldissera, E, Boffini, N et al.. The impact of 2023 EMA recommendations on patients treated with JAK inhibitors: real-life experience from a prospective monocentric cohort. Rheumatology (Oxford). 2023; :. doi: 10.1093/rheumatology/kead395. PubMed PMID:37522875 .
  27. Matteson, EL, Matucci-Cerinic, M, Kreuter, M, Burmester, GR, Dieudé, P, Emery, P et al.. Patient-level factors predictive of interstitial lung disease in rheumatoid arthritis: a systematic review. RMD Open. 2023;9 (3):. doi: 10.1136/rmdopen-2023-003059. PubMed PMID:37507209 PubMed Central PMC10387655.
  28. Lepri, G, Orlandi, M, Bellando-Randone, S, Matucci-Cerinic, M, Guiducci, S. The COVID-19 pandemic highlights the need for a psychological support in systemic sclerosis patients. Clin Exp Rheumatol. 2023;41 (8):1575-1577. doi: 10.55563/clinexprheumatol/hgkk7b. PubMed PMID:37497726 .
  29. Colalillo, A, Pellicano, C, Ananyeva, LP, Hachulla, E, Cuomo, G, Györfi, AH et al.. Tricuspid Annular Plane Systolic Excursion/Systolic Pulmonary Artery Pressure Ratio and Cardiorenal Syndrome Type 2 in the Systemic Sclerosis EUSTAR Cohort. Arthritis Care Res (Hoboken). 2023; :. doi: 10.1002/acr.25196. PubMed PMID:37458105 .
  30. Lescoat, A, Huang, S, Carreira, PE, Siegert, E, de Vries-Bouwstra, J, Distler, JHW et al.. Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database. JAMA Dermatol. 2023;159 (8):837-847. doi: 10.1001/jamadermatol.2023.1729. PubMed PMID:37378994 PubMed Central PMC10308295.
  31. Farina, N, Campochiaro, C, Lescoat, A, Benanti, G, De Luca, G, Khanna, D et al.. Drug development and novel therapeutics to ensure a personalized approach in the treatment of systemic sclerosis. Expert Rev Clin Immunol. 2023;19 (9):1131-1142. doi: 10.1080/1744666X.2023.2230370. PubMed PMID:37366065 .
  32. Ross, L, Maltez, N, Hughes, M, Schoones, JW, Baron, M, Chung, L et al.. Systemic pharmacological treatment of digital ulcers in systemic sclerosis: a systematic literature review. Rheumatology (Oxford). 2023;62 (12):3785-3800. doi: 10.1093/rheumatology/kead289. PubMed PMID:37335850 PubMed Central PMC10691932.
  33. Russo, E, Bellando-Randone, S, Carboni, D, Fioretto, BS, Romano, E, Baldi, S et al.. The differential crosstalk of the skin-gut microbiome axis as a new emerging actor in systemic sclerosis. Rheumatology (Oxford). 2023; :. doi: 10.1093/rheumatology/kead208. PubMed PMID:37154625 .
  34. Spiera, R, Kuwana, M, Khanna, D, Hummers, L, Frech, TM, Stevens, W et al.. Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis. Arthritis Rheumatol. 2023;75 (9):1608-1618. doi: 10.1002/art.42510. PubMed PMID:37098795 .
  35. Frech, TM, Poole, JL, Murtaugh, M, Matucci-Cerinic, M. Expanding the Treatment Team: What Is the Role for Occupational Therapy, Physical Therapy, Wound Care, and Nutritional Support in Systemic Sclerosis?. Rheum Dis Clin North Am. 2023;49 (2):377-387. doi: 10.1016/j.rdc.2023.01.009. PubMed PMID:37028841 .
  36. Sutera, D, Bustaffa, M, Papa, R, Matucci-Cerinic, C, Matarese, S, D'Orsi, C et al.. Corrigendum to "Clinical characterization, long-term follow-up, and response to treatment of patients with syndrome of undifferentiated recurrent fever (SURF)" Seminars in Arthritis and Rheumatism 55 (2022) 152024. Semin Arthritis Rheum. 2023;60 :152195. doi: 10.1016/j.semarthrit.2023.152195. PubMed PMID:36990005 .
  37. Andreucci, E, Fioretto, BS, Rosa, I, Matucci-Cerinic, M, Biagioni, A, Romano, E et al.. Extracellular Lactic Acidosis of the Tumor Microenvironment Drives Adipocyte-to-Myofibroblast Transition Fueling the Generation of Cancer-Associated Fibroblasts. Cells. 2023;12 (6):. doi: 10.3390/cells12060939. PubMed PMID:36980280 PubMed Central PMC10046917.
  38. Melis, MR, El Aoufy, K, Bambi, S, Bruni, C, Guiducci, S, Bellando-Randone, S et al.. Correction to: Nursing interventions for patients with rheumatic and musculoskeletal diseases on biological therapies: a systematic literature review. Clin Rheumatol. 2023;42 (6):1731. doi: 10.1007/s10067-023-06580-1. PubMed PMID:36933073 .
  39. De Angelis, R, Ferri, C, Giuggioli, D, Bajocchi, G, Dagna, L, Bellando-Randone, S et al.. Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology. RMD Open. 2023;9 (1):. doi: 10.1136/rmdopen-2022-002890. PubMed PMID:36868782 PubMed Central PMC9990652.
  40. Zhang, W, Huang, G, Zheng, K, Lin, J, Hu, S, Zheng, S et al.. Application of logistic regression and machine learning methods for idiopathic inflammatory myopathies malignancy prediction. Clin Exp Rheumatol. 2023;41 (2):330-339. doi: 10.55563/clinexprheumatol/8ievtq. PubMed PMID:36861746 .
  41. Migliore, A, Alekseeva, L, Avasthi, SR, Bannuru, RR, Chevalier, X, Conrozier, T et al.. Early Osteoarthritis Questionnaire (EOAQ): a tool to assess knee osteoarthritis at initial stage. Ther Adv Musculoskelet Dis. 2023;15 :1759720X221131604. doi: 10.1177/1759720X221131604. PubMed PMID:36860967 PubMed Central PMC9969428.
  42. Fioretto, BS, Rosa, I, Matucci-Cerinic, M, Romano, E, Manetti, M. Current Trends in Vascular Biomarkers for Systemic Sclerosis: A Narrative Review. Int J Mol Sci. 2023;24 (4):. doi: 10.3390/ijms24044097. PubMed PMID:36835506 PubMed Central PMC9965592.
  43. Campochiaro, C, De Luca, G, Lazzaroni, MG, Armentaro, G, Spinella, A, Vigone, B et al.. Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study. RMD Open. 2023;9 (1):. doi: 10.1136/rmdopen-2022-002850. PubMed PMID:36813476 PubMed Central PMC9950968.
  44. Cantoni, E, Merelli, I, Stefanoni, D, Tomelleri, A, Campochiaro, C, Giordano, V et al.. Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production. Rheumatology (Oxford). 2023;62 (10):3469-3479. doi: 10.1093/rheumatology/kead061. PubMed PMID:36802235 .
  45. Melis, MR, El Aoufy, K, Bambi, S, Bruni, C, Guiducci, S, Bellando-Randone, S et al.. Nursing interventions for patients with rheumatic and musculoskeletal diseases on biological therapies: a systematic literature review. Clin Rheumatol. 2023;42 (6):1521-1535. doi: 10.1007/s10067-023-06520-z. PubMed PMID:36801986 .
  46. Khanna, D, Denton, CP, Furst, DE, Mayes, MD, Matucci-Cerinic, M, Smith, V et al.. A 24-Week, Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis. Arthritis Rheumatol. 2023;75 (8):1434-1444. doi: 10.1002/art.42477. PubMed PMID:36787101 .
  47. Tomelleri, A, Campochiaro, C, Farina, N, Mariotti, L, Baldissera, E, Grayson, PC et al.. Effectiveness of a two-year tapered course of tocilizumab in patients with giant cell arteritis: A single-centre prospective study. Semin Arthritis Rheum. 2023;59 :152174. doi: 10.1016/j.semarthrit.2023.152174. PubMed PMID:36774660 PubMed Central PMC9992325.
  48. El Aoufy, K, Pezzutto, A, Pollina, A, Rasero, L, Bambi, S, Bellando-Randone, S et al.. Systemic Sclerosis Patients Experiencing Mindfulness-Based Stress Reduction Program: The Beneficial Effect on Their Psychological Status and Quality of Life. Int J Environ Res Public Health. 2023;20 (3):. doi: 10.3390/ijerph20032512. PubMed PMID:36767877 PubMed Central PMC9915443.
  49. Meloni, A, Gargani, L, Bruni, C, Cavallaro, C, Gobbo, M, D'Agostino, A et al.. Additional value of T1 and T2 mapping techniques for early detection of myocardial involvement in scleroderma. Int J Cardiol. 2023;376 :139-146. doi: 10.1016/j.ijcard.2023.01.066. PubMed PMID:36731634 .
  50. Peretti, S, Torracchi, S, Russo, E, Bonomi, F, Fiorentini, E, Aoufy, KE et al.. The Yin-Yang Pharmacomicrobiomics on Treatment Response in Inflammatory Arthritides: A Narrative Review. Genes (Basel). 2022;14 (1):. doi: 10.3390/genes14010089. PubMed PMID:36672830 PubMed Central PMC9859330.
  51. Matucci-Cerinic, C, Engel, F, Lipsker, D. Early morphea appearing as a port-wine stain: A clinical challenge. Ann Dermatol Venereol. 2023;150 (2):148-151. doi: 10.1016/j.annder.2022.11.003. PubMed PMID:36658067 .
  52. Damiani, A, Bartoli, F, Pacini, G, Carboni, D, Bellando Randone, S, Fiori, G et al.. Persistence of remission after lengthening of golimumab in inflammatory joint diseases. Clin Exp Rheumatol. 2023;41 (5):1088-1095. doi: 10.55563/clinexprheumatol/k76z51. PubMed PMID:36622116 .
  53. Wang, Y, Xie, X, Zheng, S, Du, G, Chen, S, Zhang, W et al.. Serum B-cell activating factor and lung ultrasound B-lines in connective tissue disease related interstitial lung disease. Front Med (Lausanne). 2022;9 :1066111. doi: 10.3389/fmed.2022.1066111. PubMed PMID:36590969 PubMed Central PMC9798453.
  54. Orlandi, M, Meliante, LA, Damiani, A, Tofani, L, Bruni, C, Guiducci, S et al.. The Role of Bronchoalveolar Lavage in Systemic Sclerosis Interstitial Lung Disease: A Systematic Literature Review. Pharmaceuticals (Basel). 2022;15 (12):. doi: 10.3390/ph15121584. PubMed PMID:36559035 PubMed Central PMC9781787.
  55. Fiorentini, E, Bonomi, F, Peretti, S, Orlandi, M, Lepri, G, Matucci Cerinic, M et al.. Potential Role of JAK Inhibitors in the Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease: A Narrative Review from Pathogenesis to Real-Life Data. Life (Basel). 2022;12 (12):. doi: 10.3390/life12122101. PubMed PMID:36556466 PubMed Central PMC9785277.
  56. Luciano, N, Fusaro, E, Ditto, MC, Ianniello, A, Bellis, E, Bruni, C et al.. Effectiveness of SB4 Transition from Originator Etanercept in Rheumatoid Arthritis and Axial Spondyloarthritis: A Subgroup Analysis from the BENEFIT Study. Rheumatol Immunol Res. 2022;3 (1):31-37. doi: 10.2478/rir-2022-0005. PubMed PMID:36467021 PubMed Central PMC9524806.
  57. Mavrogeni, S, Pepe, A, Gargani, L, Bruni, C, Quaia, E, Kitas, GD et al.. Cardiac inflammation and fibrosis patterns in systemic sclerosis, evaluated by magnetic resonance imaging: An update. Semin Arthritis Rheum. 2023;58 :152126. doi: 10.1016/j.semarthrit.2022.152126. PubMed PMID:36434895 .
  58. Agostini, E, De Luca, G, Bruni, C, Bartoli, F, Tofani, L, Campochiaro, C et al.. Corrigendum to "Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience" [Autoimmunity Reviews, Volume 20, Issue 12, December 2021, 102981]. Autoimmun Rev. 2023;22 (1):103198. doi: 10.1016/j.autrev.2022.103198. PubMed PMID:36402668 .
  59. Mormile, I, Mormile, M, Rossi, FW, Williams, M, Valente, T, Candia, C et al.. Radiological patterns and pulmonary function values of lung involvement in primary Sjögren's syndrome: A pilot analysis. Front Med (Lausanne). 2022;9 :998028. doi: 10.3389/fmed.2022.998028. PubMed PMID:36388884 PubMed Central PMC9649970.
  60. Romano, E, Rosa, I, Fioretto, BS, Matucci-Cerinic, M, Manetti, M. Increased Circulating Soluble Junctional Adhesion Molecules in Systemic Sclerosis: Association with Peripheral Microvascular Impairment. Life (Basel). 2022;12 (11):. doi: 10.3390/life12111790. PubMed PMID:36362943 PubMed Central PMC9695837.
  61. Hughes, M, Umair, HM, Sandler, RD, Alunno, A, Matucci-Cerinic, M. Harnessing the therapeutic potential therapeutic efficacy of α-1 adrenergic blockers for Raynaud's phenomenon and digital ischaemia secondary to central nervous system stimulants used for attention deficit hyperactivity disorder. Semin Arthritis Rheum. 2022;57 :152114. doi: 10.1016/j.semarthrit.2022.152114. PubMed PMID:36356481 .
  62. Ruaro, B, Matucci Cerinic, M, Salton, F, Baratella, E, Confalonieri, M, Hughes, M et al.. Editorial: Pulmonary fibrosis: One manifestation, various diseases. Front Pharmacol. 2022;13 :1027332. doi: 10.3389/fphar.2022.1027332. PubMed PMID:36324683 PubMed Central PMC9620474.
  63. Alten, R, Burmester, GR, Matucci-Cerinic, M, Salmon, JH, Lopez-Romero, P, Fakhouri, W et al.. The RA-BE-REAL Multinational, Prospective, Observational Study in Patients with Rheumatoid Arthritis Receiving Baricitinib, Targeted Synthetic, or Biologic Disease-Modifying Therapies: a 6-Month Interim Analysis. Rheumatol Ther. 2023;10 (1):73-93. doi: 10.1007/s40744-022-00500-6. PubMed PMID:36227530 PubMed Central PMC9557042.
  64. Gremese, E, Ciccia, F, Selmi, C, Cuomo, G, Foti, R, Matucci-Cerinic, M et al.. Persistence, effectiveness and safety of ustekinumab compared to TNF inhibitors in psoriatic arthritis within the Italian PsABio cohort. Clin Exp Rheumatol. 2023;41 (3):735-743. doi: 10.55563/clinexprheumatol/j33pjt. PubMed PMID:36226614 .
  65. Bandeira, M, Di Cianni, F, Marinello, D, Arnaud, L, Cannizzo, S, Carta, C et al.. An overlook on the current registries for rare and complex connective tissue diseases and the future scenario of TogethERN ReCONNET. Front Med (Lausanne). 2022;9 :889997. doi: 10.3389/fmed.2022.889997. PubMed PMID:36226147 PubMed Central PMC9549150.
  66. Talarico, R, Aguilera, S, Alexander, T, Amoura, Z, Antunes, AM, Arnaud, L et al.. Publisher Correction: The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET. Nat Rev Rheumatol. 2022;18 (12):734. doi: 10.1038/s41584-022-00862-9. PubMed PMID:36203063 PubMed Central PMC9540116.
  67. Stamenkovic, B, Stojanovic, S, Zivkovic, V, Djordjevic, D, Bojanovic, M, Stankovic, A et al.. Low-Frequency Magnetic Resonance Imaging Identifies Hand Joint Subclinical Inflammation in Systemic Sclerosis. Diagnostics (Basel). 2022;12 (9):. doi: 10.3390/diagnostics12092165. PubMed PMID:36140568 PubMed Central PMC9497728.
  68. Lepri, G, Catalano, M, Bellando-Randone, S, Pillozzi, S, Giommoni, E, Giorgione, R et al.. Systemic Sclerosis Association with Malignancy. Clin Rev Allergy Immunol. 2022;63 (3):398-416. doi: 10.1007/s12016-022-08930-4. PubMed PMID:36121543 PubMed Central PMC9674744.
  69. Campochiaro, C, Farina, N, De Luca, G, Trignani, G, Tomelleri, A, Matucci-Cerinic, M et al.. Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review. J Rheumatol. 2023;50 (1):151-153. doi: 10.3899/jrheum.220213. PubMed PMID:36109081 .
  70. Bellando-Randone, S, Del Galdo, F, Matucci-Cerinic, M. Insights into molecular and clinical characteristics of very early systemic sclerosis. Curr Opin Rheumatol. 2022;34 (6):351-356. doi: 10.1097/BOR.0000000000000903. PubMed PMID:36082752 .
  71. Campochiaro, C, Lazzaroni, MG, Bruni, C, Zanatta, E, De Luca, G, Matucci-Cerinic, M et al.. Open questions on the management of targeted therapies for the treatment of systemic sclerosis-interstitial lung disease: results of a EUSTAR survey based on a systemic literature review. Ther Adv Musculoskelet Dis. 2022;14 :1759720X221116408. doi: 10.1177/1759720X221116408. PubMed PMID:36051631 PubMed Central PMC9425887.
  72. Ruaro, B, Pozzan, R, Confalonieri, P, Tavano, S, Hughes, M, Matucci Cerinic, M et al.. Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat?. Pharmaceuticals (Basel). 2022;15 (8):. doi: 10.3390/ph15081033. PubMed PMID:36015181 PubMed Central PMC9412643.
  73. Taylor, PC, Matucci Cerinic, M, Alten, R, Avouac, J, Westhovens, R. Managing inadequate response to initial anti-TNF therapy in rheumatoid arthritis: optimising treatment outcomes. Ther Adv Musculoskelet Dis. 2022;14 :1759720X221114101. doi: 10.1177/1759720X221114101. PubMed PMID:35991524 PubMed Central PMC9386864.
  74. Ferri, C, De Angelis, R, Giuggioli, D, Bajocchi, G, Dagna, L, Zanframundo, G et al.. Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature. Autoimmun Rev. 2022;21 (10):103159. doi: 10.1016/j.autrev.2022.103159. PubMed PMID:35908642 .
  75. Garaiman, A, Steigmiller, K, Gebhard, C, Mihai, C, Dobrota, R, Bruni, C et al.. Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC model. Rheumatology (Oxford). 2023;62 (SI):SI91-SI100. doi: 10.1093/rheumatology/keac405. PubMed PMID:35904554 .
  76. Romano, E, Rosa, I, Fioretto, BS, Giuggioli, D, Manetti, M, Matucci-Cerinic, M et al.. Soluble guanylate cyclase stimulation fosters angiogenesis and blunts myofibroblast-like features of systemic sclerosis endothelial cells. Rheumatology (Oxford). 2023;62 (SI):SI125-SI137. doi: 10.1093/rheumatology/keac433. PubMed PMID:35900177 .
  77. Bonomi, F, Peretti, S, Lepri, G, Venerito, V, Russo, E, Bruni, C et al.. The Use and Utility of Machine Learning in Achieving Precision Medicine in Systemic Sclerosis: A Narrative Review. J Pers Med. 2022;12 (8):. doi: 10.3390/jpm12081198. PubMed PMID:35893293 PubMed Central PMC9331823.
  78. Hoffmann-Vold, AM, Distler, O, Bruni, C, Denton, CP, de Vries-Bouwstra, J, Matucci Cerinic, M et al.. Systemic sclerosis in the time of COVID-19. Lancet Rheumatol. 2022;4 (8):e566-e575. doi: 10.1016/S2665-9913(22)00130-8. PubMed PMID:35891634 PubMed Central PMC9302939.
  79. Romano, E, Rosa, I, Fioretto, BS, Matucci-Cerinic, M, Manetti, M. Circulating Neurovascular Guidance Molecules and Their Relationship with Peripheral Microvascular Impairment in Systemic Sclerosis. Life (Basel). 2022;12 (7):. doi: 10.3390/life12071056. PubMed PMID:35888144 PubMed Central PMC9316343.
  80. Bruni, C, Mattolini, L, Tofani, L, Gargani, L, Landini, N, Roma, N et al.. Lung Ultrasound B-Lines in the Evaluation of the Extent of Interstitial Lung Disease in Systemic Sclerosis. Diagnostics (Basel). 2022;12 (7):. doi: 10.3390/diagnostics12071696. PubMed PMID:35885600 PubMed Central PMC9316638.
  81. Santiago, T, Santos, EJF, Ruaro, B, Lepri, G, Green, L, Wildt, M et al.. Recommendations for the execution and reporting of skin ultrasound in systemic sclerosis: an international collaboration under the WSF skin ultrasound group. RMD Open. 2022;8 (2):. doi: 10.1136/rmdopen-2022-002371. PubMed PMID:35850975 PubMed Central PMC9297224.
  82. Bandini, G, Accogli, E, Cometi, L, Matucci-Cerinic, M, Moggi Pignone, A. Ultrasound assessment of splanchnic circulation in Systemic Sclerosis: a non-invasive approach for the study of bowel vasculopathy?. Eur J Intern Med. 2022;103 :120-121. doi: 10.1016/j.ejim.2022.06.024. PubMed PMID:35821193 .
  83. Campochiaro, C, Farina, N, Tomelleri, A, Ferrara, R, Viola, S, Lazzari, C et al.. Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors. Eur J Intern Med. 2022;103 :95-99. doi: 10.1016/j.ejim.2022.07.005. PubMed PMID:35821192 .
  84. Zhang, W, Huang, G, Lin, J, Lin, Q, Zheng, K, Hu, S et al.. Predictive model of risk and severity of enteritis in systemic lupus erythematosus. Lupus. 2022;31 (10):1226-1236. doi: 10.1177/09612033221110743. PubMed PMID:35750508 .
  85. Hughes, M, Huang, S, Alegre-Sancho, JJ, Carreira, PE, Engelhart, M, Hachulla, E et al.. Late skin fibrosis in systemic sclerosis: a study from the EUSTAR cohort. Rheumatology (Oxford). 2023;62 (SI):SI54-SI63. doi: 10.1093/rheumatology/keac363. PubMed PMID:35731139 .
  86. Ferri, C, Raimondo, V, Gragnani, L, Giuggioli, D, Dagna, L, Tavoni, A et al.. Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies. Curr Pharm Des. 2022;28 (24):2022-2028. doi: 10.2174/1381612828666220614151732. PubMed PMID:35726427 .
  87. Bruni, C, Occhipinti, M, Pienn, M, Camiciottoli, G, Bartolucci, M, Bosello, SL et al.. Lung vascular changes as biomarkers of severity in systemic sclerosis-associated interstitial lung disease. Rheumatology (Oxford). 2023;62 (2):696-706. doi: 10.1093/rheumatology/keac311. PubMed PMID:35708639 .
  88. Kreuter, M, Hoffmann-Vold, AM, Matucci-Cerinic, M, Saketkoo, LA, Highland, KB, Wilson, H et al.. Impact of lung function and baseline clinical characteristics on patient-reported outcome measures in systemic sclerosis-associated interstitial lung disease. Rheumatology (Oxford). 2023;62 (SI):SI43-SI53. doi: 10.1093/rheumatology/keac325. PubMed PMID:35640959 PubMed Central PMC9910566.
  89. Sutera, D, Bustaffa, M, Papa, R, Matucci-Cerinic, C, Matarese, S, D'Orsi, C et al.. Clinical characterization, long-term follow-up, and response to treatment of patients with syndrome of undifferentiated recurrent fever (SURF). Semin Arthritis Rheum. 2022;55 :152024. doi: 10.1016/j.semarthrit.2022.152024. PubMed PMID:35598507 .
  90. Abouyahya, I, Liem, SIE, Amoura, Z, Fonseca, JE, Chaigne, B, Cutolo, M et al.. Health-related quality of life in patients with mixed connective tissue disease: a comparison with matched systemic sclerosis patients. Clin Exp Rheumatol. 2022;40 Suppl 134 (5):66-70. doi: 10.55563/clinexprheumatol/x5aras. PubMed PMID:35579094 .
  91. Landini, N, Orlandi, M, Occhipinti, M, Nardi, C, Tofani, L, Bellando-Randone, S et al.. Ultrashort Echo-Time Magnetic Resonance Imaging Sequence in the Assessment of Systemic Sclerosis-Interstitial Lung Disease. J Thorac Imaging. 2023;38 (2):97-103. doi: 10.1097/RTI.0000000000000637. PubMed PMID:35482025 .
  92. Farina, N, Benanti, G, De Luca, G, Palmisano, A, Peretto, G, Tomassetti, S et al.. The Role of the Multidisciplinary Health Care Team in the Management of Patients with Systemic Sclerosis. J Multidiscip Healthc. 2022;15 :815-824. doi: 10.2147/JMDH.S295478. PubMed PMID:35480063 PubMed Central PMC9035450.
  93. Matucci-Cerinic, C, Viglizzo, G, Pastorino, C, Corcione, A, Prigione, I, Bocca, P et al.. Remission of eczema and recovery of Th1 polarization following treatment with Dupilumab in STAT3 hyper IgE syndrome. Pediatr Allergy Immunol. 2022;33 (4):e13770. doi: 10.1111/pai.13770. PubMed PMID:35470938 PubMed Central PMC9321118.
  94. Bruni, C, Buch, MH, Furst, DE, De Luca, G, Djokovic, A, Dumitru, RB et al.. Primary systemic sclerosis heart involvement: A systematic literature review and preliminary data-driven, consensus-based WSF/HFA definition. J Scleroderma Relat Disord. 2022;7 (1):24-32. doi: 10.1177/23971983211053246. PubMed PMID:35386946 PubMed Central PMC8922675.
  95. El Aoufy, K, Bruni, C, Rasero, L, Matucci Cerinic, M, Furst, DE. Patient preferences for systemic sclerosis treatment: A descriptive study within an Italian cohort. J Scleroderma Relat Disord. 2021;6 (2):165-169. doi: 10.1177/2397198320971984. PubMed PMID:35386742 PubMed Central PMC8892923.
  96. Baldini, C, Arnaud, L, Avčin, T, Beretta, L, Bellocchi, C, Bouillot, C et al.. Sjögren's syndrome and other rare and complex connective tissue diseases: an intriguing liaison. Clin Exp Rheumatol. 2022;40 Suppl 134 (5):103-112. doi: 10.55563/clinexprheumatol/3y0hqs. PubMed PMID:35349420 .
  97. Talarico, R, Aguilera, S, Alexander, T, Amoura, Z, Andersen, J, Arnaud, L et al.. The added value of a European Reference Network on rare and complex connective tissue and musculoskeletal diseases: insights after the first 5 years of the ERN ReCONNET. Clin Exp Rheumatol. 2022;40 Suppl 134 (5):3-11. doi: 10.55563/clinexprheumatol/d2qz38. PubMed PMID:35349419 .
  98. Zanatta, E, Huscher, D, Ortolan, A, Avouac, J, Airò, P, Balbir-Gurman, A et al.. Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort. Rheumatology (Oxford). 2022;61 (12):4786-4796. doi: 10.1093/rheumatology/keac188. PubMed PMID:35348643 .
  99. Ruaro, B, Salton, F, Baratella, E, Confalonieri, P, Geri, P, Pozzan, R et al.. An Overview of Different Techniques for Improving the Treatment of Pulmonary Hypertension Secondary in Systemic Sclerosis Patients. Diagnostics (Basel). 2022;12 (3):. doi: 10.3390/diagnostics12030616. PubMed PMID:35328169 PubMed Central PMC8947575.
  100. Manetti, M, Rosa, I, Fioretto, BS, Matucci-Cerinic, M, Romano, E. Decreased Serum Levels of SIRT1 and SIRT3 Correlate with Severity of Skin and Lung Fibrosis and Peripheral Microvasculopathy in Systemic Sclerosis. J Clin Med. 2022;11 (5):. doi: 10.3390/jcm11051362. PubMed PMID:35268452 PubMed Central PMC8910971.
  101. Cavagna, L, Meloni, F, Meyer, A, Sambataro, G, Belliato, M, De Langhe, E et al.. Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies. Clin Exp Rheumatol. 2022;40 (2):274-283. doi: 10.55563/clinexprheumatol/di1083. PubMed PMID:35200123 .
  102. De Luca, G, Palmisano, A, Campochiaro, C, Vignale, D, Cavalli, G, Bruno, E et al.. Cardiac magnetic resonance in systemic sclerosis myocarditis: the value of T2 mapping to detect myocardial inflammation. Rheumatology (Oxford). 2022;61 (11):4409-4419. doi: 10.1093/rheumatology/keac098. PubMed PMID:35188182 .
  103. Landini, N, Orlandi, M, Bruni, C, Carlesi, E, Nardi, C, Calistri, L et al.. Computed Tomography Predictors of Mortality or Disease Progression in Systemic Sclerosis-Interstitial Lung Disease: A Systematic Review. Front Med (Lausanne). 2021;8 :807982. doi: 10.3389/fmed.2021.807982. PubMed PMID:35155484 PubMed Central PMC8829727.
  104. Bruni, C, Gentileschi, S, Pacini, G, Bardelli, M, Tofani, L, Bartoli, F et al.. Switching from originator adalimumab to biosimilar SB5 in a rheumatology cohort: persistence on treatment, predictors of drug interruption and safety analysis. Ther Adv Musculoskelet Dis. 2021;13 :1759720X211033679. doi: 10.1177/1759720X211033679. PubMed PMID:35116080 PubMed Central PMC8804457.
  105. Bruni, C, Cigolini, C, Tesei, G, Cometi, L, Bartoli, F, Fiori, G et al.. Combination of denosumab and biologic DMARDs in inflammatory muscle-skeletal diseases and connective tissue diseases. Eur J Rheumatol. 2021;8 (4):190-195. doi: 10.5152/eurjrheum.2020.21162. PubMed PMID:35110179 PubMed Central PMC10176229.
  106. De Luca, G, Matucci-Cerinic, M, Dagna, L. Improvements of vascular outcomes in systemic sclerosis: halfway through, but still far to go. Rheumatology (Oxford). 2022;61 (7):2714-2716. doi: 10.1093/rheumatology/keac056. PubMed PMID:35094069 .
  107. Santaniello, M, Matucci-Cerinic, C, Natoli, V, Trincianti, C, Ridella, F, Ravelli, A et al.. Childhood multisystem inflammatory syndrome associated with COVID-19 (MIS-C): Distinct from Kawasaki disease or part of the same spectrum?. Pediatr Allergy Immunol. 2022;33 Suppl 27 (Suppl 27):102-104. doi: 10.1111/pai.13645. PubMed PMID:35080303 PubMed Central PMC9306717.
  108. Longo, D, Branchi, E, Matucci-Cerinic, P, Bagni, MA, Matucci-Cerinic, M, Melchiorre, D et al.. Shoulder impingement syndrome in water polo players: muscle shortening manoeuvre controls pain intensity, recovers function and normalizes sonographic parameters. J Ultrasound. 2022;25 (3):667-673. doi: 10.1007/s40477-021-00645-0. PubMed PMID:35060097 PubMed Central PMC9402839.
  109. Bandini, G, Cometi, L, Accogli, E, Domanico, A, Tofani, L, Bruni, C et al.. Ultrasound evaluation of bowel vasculopathy in systemic sclerosis. Eur J Intern Med. 2022;100 :62-68. doi: 10.1016/j.ejim.2022.01.026. PubMed PMID:35058148 .
  110. Paoloni, M, Agostini, F, Bernasconi, S, Bona, G, Cisari, C, Fioranelli, M et al.. Information Survey on the Use of Complementary and Alternative Medicine. Medicina (Kaunas). 2022;58 (1):. doi: 10.3390/medicina58010125. PubMed PMID:35056433 PubMed Central PMC8781067.
  111. Lepri, G, Bellando Randone, S, Matucci Cerinic, M, Guiducci, S. Early diagnosis of systemic sclerosis, where do we stand today?. Expert Rev Clin Immunol. 2022;18 (1):1-3. doi: 10.1080/1744666X.2022.2015327. PubMed PMID:35023438 .
  112. Chung, L, Spino, C, McLain, R, Johnson, SR, Denton, CP, Molitor, JA et al.. Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial. Lancet Rheumatol. 2020;2 (12):e743-e753. doi: 10.1016/s2665-9913(20)30237-x. PubMed PMID:34966900 PubMed Central PMC8713509.
  113. Tomassetti, S, Colby, TV, Wells, AU, Poletti, V, Costabel, U, Matucci-Cerinic, M et al.. Bronchoalveolar lavage and lung biopsy in connective tissue diseases, to do or not to do?. Ther Adv Musculoskelet Dis. 2021;13 :1759720X211059605. doi: 10.1177/1759720X211059605. PubMed PMID:34900002 PubMed Central PMC8664307.
  114. Migliore, A, Gigliucci, G, Alekseeva, L, Bannuru, RR, Blicharski, T, Diracoglu, D et al.. Systematic Literature Review and Expert Opinion for the Use of Viscosupplementation with Hyaluronic Acid in Different Localizations of Osteoarthritis. Orthop Res Rev. 2021;13 :255-273. doi: 10.2147/ORR.S336185. PubMed PMID:34880685 PubMed Central PMC8648269.
  115. Tufan, A, Matucci-Cerinic, M. Immune dysfunction in COVID-19 and judicious use of antirheumatic drugs for the treatment of hyperinflammation. Turk J Med Sci. 2021;51 (SI-1):3391-3404. doi: 10.3906/sag-2110-179. PubMed PMID:34844296 PubMed Central PMC8771052.
  116. Rosa, I, Romano, E, Fioretto, BS, Guasti, D, Ibba-Manneschi, L, Matucci-Cerinic, M et al.. Scleroderma-like Impairment in the Network of Telocytes/CD34+ Stromal Cells in the Experimental Mouse Model of Bleomycin-Induced Dermal Fibrosis. Int J Mol Sci. 2021;22 (22):. doi: 10.3390/ijms222212407. PubMed PMID:34830288 PubMed Central PMC8620338.
  117. Caforio, ALP, De Luca, G, Baritussio, A, Seguso, M, Gallo, N, Bison, E et al.. Serum Organ-Specific Anti-Heart and Anti-Intercalated Disk Autoantibodies as New Autoimmune Markers of Cardiac Involvement in Systemic Sclerosis: Frequency, Clinical and Prognostic Correlates. Diagnostics (Basel). 2021;11 (11):. doi: 10.3390/diagnostics11112165. PubMed PMID:34829512 PubMed Central PMC8625508.
  118. Becker, MO, Dobrota, R, Garaiman, A, Debelak, R, Fligelstone, K, Tyrrell Kennedy, A et al.. Development and validation of a patient-reported outcome measure for systemic sclerosis: the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaire. Ann Rheum Dis. 2022;81 (4):507-515. doi: 10.1136/annrheumdis-2021-220702. PubMed PMID:34824049 .
  119. Campochiaro, C, Tomelleri, A, Farina, N, Cavalli, G, De Luca, G, Palmisano, A et al.. Myocarditis as a manifestation of Erdheim-Chester Disease: successful use of anti- IL1 and BRAF inhibitor combination therapy. Scand J Rheumatol. 2022;51 (3):243-245. doi: 10.1080/03009742.2021.1992846. PubMed PMID:34788207 .
  120. De Angelis, R, Giuggioli, D, Bajocchi, G, Dagna, L, Zanframundo, G, Foti, R et al.. Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology. J Rheumatol. 2022;49 (2):176-185. doi: 10.3899/jrheum.210794. PubMed PMID:34782448 .
  121. El Aoufy, K, Melis, MR, Bellando Randone, S, Blagojevic, J, Bartoli, F, Fiori, G et al.. The positive side of the coin: Sars-Cov-2 pandemic has taught us how much Telemedicine is useful as standard of care procedure in real life. Clin Rheumatol. 2022;41 (2):573-579. doi: 10.1007/s10067-021-05975-2. PubMed PMID:34739619 PubMed Central PMC8569841.
  122. Tomassetti, S, Ravaglia, C, Puglisi, S, Ryu, JH, Colby, TV, Cavazza, A et al.. Impact of Lung Biopsy Information on Treatment Strategy of Patients with Interstitial Lung Diseases. Ann Am Thorac Soc. 2022;19 (5):737-745. doi: 10.1513/AnnalsATS.202104-466OC. PubMed PMID:34739359 .
  123. Agostini, E, De Luca, G, Bruni, C, Bartoli, F, Tofani, L, Campochiaro, C et al.. Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience. Autoimmun Rev. 2021;20 (12):102981. doi: 10.1016/j.autrev.2021.102981. PubMed PMID:34718166 .
  124. Campochiaro, C, Tomelleri, A, Matucci-Cerinic, M, Dagna, L. One year later: The case of tocilizumab in COVID-19. Eur J Intern Med. 2022;95 :5-6. doi: 10.1016/j.ejim.2021.10.024. PubMed PMID:34711474 PubMed Central PMC8536517.
  125. Gargani, L, Romei, C, Bruni, C, Lepri, G, El-Aoufy, K, Orlandi, M et al.. Lung ultrasound B-lines in systemic sclerosis: cut-off values and methodological indications for interstitial lung disease screening. Rheumatology (Oxford). 2022;61 (SI):SI56-SI64. doi: 10.1093/rheumatology/keab801. PubMed PMID:34698807 .
  126. Tonelli, F, Rossi, M, Matucci Cerinic, P. Concomitance of intraductal papillary mucinous neoplasm with pancreatic stones: indication for immediate surgery. Updates Surg. 2022;74 (3):1165-1167. doi: 10.1007/s13304-021-01185-2. PubMed PMID:34674137 .
  127. Romano, E, Rosa, I, Fioretto, BS, Kosalka-Wegiel, J, Sticchi, E, Bellando-Randone, S et al.. A candidate gene study reveals association between a variant of the SRp55 splicing factor gene and systemic sclerosis. Clin Exp Rheumatol. 2022;40 (10):1921-1925. doi: 10.55563/clinexprheumatol/mpgq0y. PubMed PMID:34665708 .
  128. Umair, HM, Sandler, RD, Alunno, A, Matucci-Cerinic, M, Hughes, M. Association between central nervous system stimulants used to treat attention deficit hyperactivity disorder (ADHD) and Raynaud's phenomenon: A scoping review. Semin Arthritis Rheum. 2021;51 (6):1200-1204. doi: 10.1016/j.semarthrit.2021.09.002. PubMed PMID:34655948 .
  129. Paderi, A, Gambale, E, Botteri, C, Giorgione, R, Lavacchi, D, Brugia, M et al.. Association of Systemic Steroid Treatment and Outcome in Patients Treated with Immune Checkpoint Inhibitors: A Real-World Analysis. Molecules. 2021;26 (19):. doi: 10.3390/molecules26195789. PubMed PMID:34641331 PubMed Central PMC8510096.
  130. Sandborn, WJ, Feagan, BG, D'Haens, G, Wolf, DC, Jovanovic, I, Hanauer, SB et al.. Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis. N Engl J Med. 2021;385 (14):1280-1291. doi: 10.1056/NEJMoa2033617. PubMed PMID:34587385 .
  131. De Luca, R, Maresca, M, Orlandi, M, Bruni, C, Solanki, K, Wang, Y et al.. The Emerging Challenge of Pain in Systemic Sclerosis: Similarity to the Pain Experience Reported by Sjőgren's Syndrome Patients. Rheumatol Immunol Res. 2021;2 (2):113-119. doi: 10.2478/rir-2021-0015. PubMed PMID:36465974 PubMed Central PMC9524780.
  132. Kuwana, M, Allanore, Y, Denton, CP, Distler, JHW, Steen, V, Khanna, D et al.. Nintedanib in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease: Subgroup Analyses by Autoantibody Status and Modified Rodnan Skin Thickness Score. Arthritis Rheumatol. 2022;74 (3):518-526. doi: 10.1002/art.41965. PubMed PMID:34514739 PubMed Central PMC9306495.
  133. Ferri, C, Giuggioli, D, Raimondo, V, L'Andolina, M, Dagna, L, Tavoni, A et al.. Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments. Curr Pharm Des. 2021;27 (41):4245-4252. doi: 10.2174/1381612827666210903103935. PubMed PMID:34477509 .
  134. Wang, Y, Xie, X, Zhang, C, Su, M, Gao, S, Wang, J et al.. Rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren's syndrome shared megakaryocyte expansion in peripheral blood. Ann Rheum Dis. 2022;81 (3):379-385. doi: 10.1136/annrheumdis-2021-220066. PubMed PMID:34462261 PubMed Central PMC8862024.
  135. Wang, Y, Chen, S, Zheng, S, Lin, J, Hu, S, Zhuang, J et al.. The role of lung ultrasound B-lines and serum KL-6 in the screening and follow-up of rheumatoid arthritis patients for an identification of interstitial lung disease: review of the literature, proposal for a preliminary algorithm, and clinical application to cases. Arthritis Res Ther. 2021;23 (1):212. doi: 10.1186/s13075-021-02586-9. PubMed PMID:34391465 PubMed Central PMC8364073.
  136. Spiera, R, Khanna, D, Kuwana, M, Furst, DE, Frech, TM, Hummers, L et al.. A randomised, double-blind, placebo-controlled phase 3 study of lenabasum in diffuse cutaneous systemic sclerosis: RESOLVE-1 design and rationale. Clin Exp Rheumatol. 2021;39 Suppl 131 (4):124-133. doi: 10.55563/clinexprheumatol/i80zh7. PubMed PMID:34323681 .
  137. Orlandi, M, Landini, N, Sambataro, G, Nardi, C, Tofani, L, Bruni, C et al.. The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19. Rheumatology (Oxford). 2022;61 (4):1600-1609. doi: 10.1093/rheumatology/keab615. PubMed PMID:34320649 .
  138. Karalilova, RV, Batalov, ZA, Sapundzhieva, TL, Matucci-Cerinic, M, Batalov, AZ. Tofacitinib in the treatment of skin and musculoskeletal involvement in patients with systemic sclerosis, evaluated by ultrasound. Rheumatol Int. 2021;41 (10):1743-1753. doi: 10.1007/s00296-021-04956-7. PubMed PMID:34313812 PubMed Central PMC8390399.
  139. Mahran, SA, Galluccio, F, Khedr, TM, Elsonbaty, A, Allam, AE, Garcia Martos, A et al.. Peripheral neuropathy in systemic lupus erythematosus: what can neuromuscular ultrasonography (NMUS) tell us? A cross-sectional study. Lupus Sci Med. 2021;8 (1):. doi: 10.1136/lupus-2021-000521. PubMed PMID:34312211 PubMed Central PMC8314698.
  140. Atzori, L, Ferreli, C, Matucci-Cerinic, C, Pilloni, L, Rongioletti, F. Primary Localized Cutaneous Nodular Amyloidosis and Limited Cutaneous Systemic Sclerosis: Additional Cases with Dermatoscopic and Histopathological Correlation of Amyloid Deposition. Dermatopathology (Basel). 2021;8 (3):229-235. doi: 10.3390/dermatopathology8030028. PubMed PMID:34287266 PubMed Central PMC8293241.
  141. Matucci-Cerinic, M, Hughes, M, Taliani, G, Kahaleh, B. Similarities between COVID-19 and systemic sclerosis early vasculopathy: A "viral" challenge for future research in scleroderma. Autoimmun Rev. 2021;20 (10):102899. doi: 10.1016/j.autrev.2021.102899. PubMed PMID:34274540 PubMed Central PMC8280663.
  142. Campochiaro, C, De Luca, G, Farina, N, Vignale, D, Palmisano, A, Matucci-Cerinic, M et al.. Severe acute respiratory syndrome coronavirus-2-induced flare of systemic sclerosis. Scand J Rheumatol. 2022;51 (2):156-158. doi: 10.1080/03009742.2021.1932582. PubMed PMID:34232807 .
  143. Bellando-Randone, S, Russo, E, Venerito, V, Matucci-Cerinic, M, Iannone, F, Tangaro, S et al.. Exploring the Oral Microbiome in Rheumatic Diseases, State of Art and Future Prospective in Personalized Medicine with an AI Approach. J Pers Med. 2021;11 (7):. doi: 10.3390/jpm11070625. PubMed PMID:34209167 PubMed Central PMC8306274.
  144. Melchiorre, D, Ceccherini, MT, Romano, E, Cometi, L, El-Aoufy, K, Bellando-Randone, S et al.. Oral Lactobacillus Species in Systemic Sclerosis. Microorganisms. 2021;9 (6):. doi: 10.3390/microorganisms9061298. PubMed PMID:34203626 PubMed Central PMC8232208.
  145. Romano, E, Rosa, I, Fioretto, BS, Matucci-Cerinic, M, Manetti, M. New Insights into Profibrotic Myofibroblast Formation in Systemic Sclerosis: When the Vascular Wall Becomes the Enemy. Life (Basel). 2021;11 (7):. doi: 10.3390/life11070610. PubMed PMID:34202703 PubMed Central PMC8307837.
  146. Matucci-Cerinic, C, Caorsi, R, Consolaro, A, Rosina, S, Civino, A, Ravelli, A et al.. Multisystem Inflammatory Syndrome in Children: Unique Disease or Part of the Kawasaki Disease Spectrum?. Front Pediatr. 2021;9 :680813. doi: 10.3389/fped.2021.680813. PubMed PMID:34178896 PubMed Central PMC8220809.
  147. Maddali Bongi, S, Passalacqua, M, Landi, G, Mikhaylova, S, Tofani, L, Del Rosso, A et al.. Rehabilitation of the face and temporomandibular joint in systemic sclerosis. Ther Adv Musculoskelet Dis. 2021;13 :1759720X211020171. doi: 10.1177/1759720X211020171. PubMed PMID:34163540 PubMed Central PMC8191075.
  148. Hughes, M, Heal, C, Henes, J, Balbir-Gurman, A, Distler, JHW, Airò, P et al.. Digital pitting scars are associated with a severe disease course and death in systemic sclerosis: a study from the EUSTAR cohort. Rheumatology (Oxford). 2022;61 (3):1141-1147. doi: 10.1093/rheumatology/keab510. PubMed PMID:34146098 .
  149. Hughes, M, Allanore, Y, El Aoufy, K, Denton, CP, Khanna, D, Krieg, T et al.. A Practical Approach to the Management of Digital Ulcers in Patients With Systemic Sclerosis: A Narrative Review. JAMA Dermatol. 2021;157 (7):851-858. doi: 10.1001/jamadermatol.2021.1463. PubMed PMID:34037677 .
  150. Tesei, G, Cometi, L, Nacci, F, Terenzi, R, Tofani, L, Capassoni, M et al.. Baricitinib in the treatment of rheumatoid arthritis: clinical and ultrasound evaluation of a real-life single-centre experience. Ther Adv Musculoskelet Dis. 2021;13 :1759720X211014019. doi: 10.1177/1759720X211014019. PubMed PMID:34025783 PubMed Central PMC8120535.
  151. De Luca, G, Tomelleri, A, Dagna, L, Matucci-Cerinic, M. The target on B cells in Systemic Sclerosis: a "midsummer dream" to extinguish inflammation and prevent early disease progression to fibrosis. Clin Rheumatol. 2021;40 (7):2529-2533. doi: 10.1007/s10067-021-05733-4. PubMed PMID:34021841 .
  152. Matucci-Cerinic, C, Viglizzo, G, Ravelli, A, Occella, C. Neonatal lupus erythematosus in dizygotic twins with anti-RNP antibodies. Clin Exp Rheumatol. 2021;39 (6):1446. doi: 10.55563/clinexprheumatol/88qnuv. PubMed PMID:34001302 .
  153. Nevskaya, T, Pope, JE, Turk, MA, Shu, J, Marquardt, A, van den Hoogen, F et al.. Systematic Analysis of the Literature in Search of Defining Systemic Sclerosis Subsets. J Rheumatol. 2021;48 (11):1698-1717. doi: 10.3899/jrheum.201594. PubMed PMID:33993109 PubMed Central PMC10613330.
  154. Galluccio, F, D'Angela, D, Polistena, B, Porta, F, Barskova, T, Tofani, L et al.. Comparison of three treatment protocols with intra-articular low or intermediate molecular weight hyaluronic acid in early symptomatic knee osteoarthritis. Ther Adv Musculoskelet Dis. 2021;13 :1759720X21994024. doi: 10.1177/1759720X21994024. PubMed PMID:33959197 PubMed Central PMC8064515.
  155. Russo, B, Ben Shimol, J, Matucci-Cerinic, M, Bruni, C. Systemic sclerosis and COVID-19: what's new in the literature. Clin Exp Rheumatol. 2021;39 Suppl 131 (4):157-158. doi: 10.55563/clinexprheumatol/muidl3. PubMed PMID:33938792 .
  156. Oliveira Mendonça, L, Matucci-Cerinic, C, Terranova, P, Casabona, F, Bovis, F, Caorsi, R et al.. The challenge of early diagnosis of autoimmune lymphoproliferative syndrome in children with suspected autoinflammatory/autoimmune disorders. Rheumatology (Oxford). 2022;61 (2):696-704. doi: 10.1093/rheumatology/keab361. PubMed PMID:33909886 .
  157. Lescoat, A, Varga, J, Matucci-Cerinic, M, Khanna, D. New promising drugs for the treatment of systemic sclerosis: pathogenic considerations, enhanced classifications, and personalized medicine. Expert Opin Investig Drugs. 2021;30 (6):635-652. doi: 10.1080/13543784.2021.1923693. PubMed PMID:33909517 PubMed Central PMC8292968.
  158. De Luca, G, Cavalli, G, Campochiaro, C, Bruni, C, Tomelleri, A, Dagna, L et al.. Interleukin-1 and Systemic Sclerosis: Getting to the Heart of Cardiac Involvement. Front Immunol. 2021;12 :653950. doi: 10.3389/fimmu.2021.653950. PubMed PMID:33833766 PubMed Central PMC8021854.
  159. Romano, E, Rosa, I, Fioretto, BS, Matucci-Cerinic, M, Manetti, M. The Role of Pro-fibrotic Myofibroblasts in Systemic Sclerosis: From Origin to Therapeutic Targeting. Curr Mol Med. 2022;22 (3):209-239. doi: 10.2174/0929867328666210325102749. PubMed PMID:33823766 .
  160. d'Alessandro, M, Bellisai, F, Bergantini, L, Cameli, P, D'Alessandro, R, Mazzei, MA et al.. Prognostic role of KL-6 in SSc-ILD patients with pleuroparenchymal fibroelastosis. Eur J Clin Invest. 2021;51 (8):e13543. doi: 10.1111/eci.13543. PubMed PMID:33759179 .
  161. Hughes, M, Allanore, Y, Chung, L, Pauling, JD, Denton, CP, Matucci-Cerinic, M et al.. Author Correction: Raynaud phenomenon and digital ulcers in systemic sclerosis. Nat Rev Rheumatol. 2021;17 (4):246. doi: 10.1038/s41584-021-00591-5. PubMed PMID:33750917 .
  162. Baimukhamedov, C, Barskova, T, Matucci-Cerinic, M. Arthritis after SARS-CoV-2 infection. Lancet Rheumatol. 2021;3 (5):e324-e325. doi: 10.1016/S2665-9913(21)00067-9. PubMed PMID:33748780 PubMed Central PMC7963449.
  163. Hughes, M, Kahaleh, B, Denton, CP, Mason, JC, Matucci-Cerinic, M. ANCA in systemic sclerosis, when vasculitis overlaps with vasculopathy: a devastating combination of pathologies. Rheumatology (Oxford). 2021;60 (12):5509-5516. doi: 10.1093/rheumatology/keab278. PubMed PMID:33744916 .
  164. Lazzeri, C, Bonizzoli, M, Batacchi, S, Socci, F, Matucci-Cerinic, M, Peris, A et al.. Combined lung and cardiac ultrasound in COVID-related acute respiratory distress syndrome. Intern Emerg Med. 2021;16 (7):1779-1785. doi: 10.1007/s11739-021-02646-7. PubMed PMID:33704675 PubMed Central PMC7947148.
  165. Giuggioli, D, Bruni, C, Cacciapaglia, F, Dardi, F, De Cata, A, Del Papa, N et al.. Pulmonary arterial hypertension: guidelines and unmet clinical needs. Reumatismo. 2021;72 (4):228-246. doi: 10.4081/reumatismo.2020.1310. PubMed PMID:33677950 .
  166. Suliman, YA, Bruni, C, Hughes, M, Matucci-Cerinic, M, Furst, DE. Ultrasonographic imaging of systemic sclerosis digital ulcers: A systematic literature review and validation steps. Semin Arthritis Rheum. 2021;51 (2):425-429. doi: 10.1016/j.semarthrit.2021.02.008. PubMed PMID:33677309 .
  167. Ruaro, B, Confalonieri, M, Matucci-Cerinic, M, Salton, F, Confalonieri, P, Santagiuliana, M et al.. The Treatment of Lung Involvement in Systemic Sclerosis. Pharmaceuticals (Basel). 2021;14 (2):. doi: 10.3390/ph14020154. PubMed PMID:33668530 PubMed Central PMC7918752.
  168. Cappelli, F, Zampieri, M, Fumagalli, C, Nardi, G, Del Monaco, G, Matucci Cerinic, M et al.. Tenosynovial complications identify TTR cardiac amyloidosis among patients with hypertrophic cardiomyopathy phenotype. J Intern Med. 2021;289 (6):831-839. doi: 10.1111/joim.13200. PubMed PMID:33615623 .
  169. Cox, M, Sandler, RD, Matucci-Cerinic, M, Hughes, M. Bone health in idiopathic inflammatory myopathies. Autoimmun Rev. 2021;20 (4):102782. doi: 10.1016/j.autrev.2021.102782. PubMed PMID:33609795 .
  170. Coi, A, Barsotti, S, Santoro, M, Almerigogna, F, Bargagli, E, Caproni, M et al.. Epidemiology of systemic sclerosis: a multi-database population-based study in Tuscany (Italy). Orphanet J Rare Dis. 2021;16 (1):90. doi: 10.1186/s13023-021-01733-4. PubMed PMID:33596949 PubMed Central PMC7890847.
  171. Rosa, I, Romano, E, Fioretto, BS, Matucci-Cerinic, M, Manetti, M. Adipose-derived stem cells: Pathophysiologic implications vs therapeutic potential in systemic sclerosis. World J Stem Cells. 2021;13 (1):30-48. doi: 10.4252/wjsc.v13.i1.30. PubMed PMID:33584978 PubMed Central PMC7859990.
  172. Bruni, C, Cometi, L, Gigante, A, Rosato, E, Matucci-Cerinic, M. Prediction and primary prevention of major vascular complications in systemic sclerosis. Eur J Intern Med. 2021;87 :51-58. doi: 10.1016/j.ejim.2021.01.022. PubMed PMID:33551291 .
  173. Hughes, M, Bruni, C, Ruaro, B, Confalonieri, M, Matucci-Cerinic, M, Bellando-Randone, S et al.. Digital Ulcers in Systemic Sclerosis. Presse Med. 2021;50 (1):104064. doi: 10.1016/j.lpm.2021.104064. PubMed PMID:33548375 .
  174. Ferri, C, Giuggioli, D, Raimondo, V, Dagna, L, Riccieri, V, Zanatta, E et al.. COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study. Lancet Rheumatol. 2021;3 (3):e166-e168. doi: 10.1016/S2665-9913(21)00007-2. PubMed PMID:33521657 PubMed Central PMC7836813.
  175. Denton, CP, Campochiaro, C, Bruni, C, Distler, O, Iagnocco, A, Matucci Cerinic, M et al.. COVID-19 and systemic sclerosis: Rising to the challenge of a pandemic. J Scleroderma Relat Disord. 2021;6 (1):58-65. doi: 10.1177/2397198320963393. PubMed PMID:35382249 PubMed Central PMC8922634.
  176. Landini, N, Orlandi, M, Fusaro, M, Ciet, P, Nardi, C, Bertolo, S et al.. The Role of Imaging in COVID-19 Pneumonia Diagnosis and Management: Main Positions of the Experts, Key Imaging Features and Open Answers. J Cardiovasc Echogr. 2020;30 (Suppl 2):S25-S30. doi: 10.4103/jcecho.jcecho_59_20. PubMed PMID:33489733 PubMed Central PMC7811702.
  177. Andreucci, E, Margheri, F, Peppicelli, S, Bianchini, F, Ruzzolini, J, Laurenzana, A et al.. Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis. Rheumatology (Oxford). 2021;60 (10):4508-4519. doi: 10.1093/rheumatology/keab022. PubMed PMID:33471123 .
  178. Talarico, R, Aguilera, S, Alexander, T, Amoura, Z, Antunes, AM, Arnaud, L et al.. The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET. Nat Rev Rheumatol. 2021;17 (3):177-184. doi: 10.1038/s41584-020-00565-z. PubMed PMID:33408338 PubMed Central PMC7786339.
  179. Bruni, C, Matucci-Cerinic, M. Response to: 'Correspondence on 'Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management'' by Snarskaya and Vasileva. Ann Rheum Dis. 2023;82 (2):e37. doi: 10.1136/annrheumdis-2020-219533. PubMed PMID:33408075 .
  180. Rosa, I, Faussone-Pellegrini, MS, Romano, E, Ibba-Manneschi, L, Matucci-Cerinic, M, Manetti, M et al.. Impairment in the telocyte/CD34+ stromal cell network in human rheumatoid arthritis synovium. J Cell Mol Med. 2021;25 (4):2274-2278. doi: 10.1111/jcmm.16225. PubMed PMID:33350073 PubMed Central PMC7882959.
  181. Orlandi, M, Landini, N, Bruni, C, Sambataro, G, Nardi, C, Bargagli, E et al.. Pleuroparenchymal fibroelastosis in rheumatic autoimmune diseases: a systematic literature review. Rheumatology (Oxford). 2020;59 (12):3645-3656. doi: 10.1093/rheumatology/keaa451. PubMed PMID:33313932 .
  182. Orlandi, M, Landini, N, Bruni, C, Colagrande, S, Matucci-Cerinic, M, Kuwana, M et al.. Infection or Autoimmunity? The Clinical Challenge of Interstitial Lung Disease in Systemic Sclerosis During the COVID-19 Pandemic. J Rheumatol. 2021;48 (5):790-792. doi: 10.3899/jrheum.200832. PubMed PMID:33262297 .
  183. Cometi, L, Bruni, C, Passavanti, S, Tofani, L, Bartoli, F, Fiori, G et al.. Risk of Malignancy and Biologic Therapy in Rheumatic Inflammatory Diseases: A Single-center Experience. Rheumatol Immunol Res. 2020;1 (1):39-45. doi: 10.2478/rir-2020-0001. PubMed PMID:36465081 PubMed Central PMC9524767.
  184. Johnson, SR, van den Hoogen, F, Devakandan, K, Matucci-Cerinic, M, Pope, JE. Systemic sclerosis: To subset or not to subset, that is the question. Eur J Rheumatol. 2020;7 (Suppl 3):S222-S227. doi: 10.5152/eurjrheum.2020.19116. PubMed PMID:33164736 PubMed Central PMC7647684.
  185. Del Galdo, F, Matucci-Cerinic, M. A special European Journal of Rheumatology issue on systemic sclerosis: What and why?. Eur J Rheumatol. 2020;7 (Suppl 3):S137-S138. doi: 10.5152/eurjrheum.2020.090121. PubMed PMID:33164730 PubMed Central PMC7647686.
  186. Gargani, L, Bruni, C, De Marchi, D, Romei, C, Guiducci, S, Bellando-Randone, S et al.. Lung magnetic resonance imaging in systemic sclerosis: a new promising approach to evaluate pulmonary involvement and progression. Clin Rheumatol. 2021;40 (5):1903-1912. doi: 10.1007/s10067-020-05491-9. PubMed PMID:33161470 .
  187. Bruni, C, Gentileschi, S, Pacini, G, Baldi, C, Capassoni, M, Tofani, L et al.. The switch from etanercept originator to SB4: data from a real-life experience on tolerability and persistence on treatment in joint inflammatory diseases. Ther Adv Musculoskelet Dis. 2020;12 :1759720X20964031. doi: 10.1177/1759720X20964031. PubMed PMID:33133246 PubMed Central PMC7576915.
  188. Benvenuti, F, Zanatta, E, Avouac, J, Müller-Ladner, U, Cozzi, F, Hoffmann-Vold, AM et al.. The power of the EUSTAR cohort: key findings to date and implications for management of systemic sclerosis patients. Expert Rev Clin Immunol. 2020;16 (11):1065-1074. doi: 10.1080/1744666X.2021.1836962. PubMed PMID:33076716 .
  189. Maraghelli, D, Brandi, ML, Matucci Cerinic, M, Peired, AJ, Colagrande, S. Edema-like marrow signal intensity: a narrative review with a pictorial essay. Skeletal Radiol. 2021;50 (4):645-663. doi: 10.1007/s00256-020-03632-4. PubMed PMID:33029648 PubMed Central PMC7875957.
  190. Khanna, D, Lin, CJF, Furst, DE, Goldin, J, Kim, G, Kuwana, M et al.. Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Respir Med. 2020;8 (10):963-974. doi: 10.1016/S2213-2600(20)30318-0. PubMed PMID:32866440 .
  191. Bruni, C, Tashkin, DP, Steen, V, Allanore, Y, Distler, O, Grotts, J et al.. Intravenous versus oral cyclophosphamide for lung and/or skin fibrosis in systemic sclerosis: an indirect comparison from EUSTAR and randomised controlled trials. Clin Exp Rheumatol. 2020;38 Suppl 125 (3):161-168. . PubMed PMID:32865169 .
  192. Romano, E, Rosa, I, Fioretto, BS, Lucattelli, E, Innocenti, M, Ibba-Manneschi, L et al.. A Two-Step Immunomagnetic Microbead-Based Method for the Isolation of Human Primary Skin Telocytes/CD34+ Stromal Cells. Int J Mol Sci. 2020;21 (16):. doi: 10.3390/ijms21165877. PubMed PMID:32824287 PubMed Central PMC7461544.
  193. Vannucchi, AM, Sordi, B, Morettini, A, Nozzoli, C, Poggesi, L, Pieralli, F et al.. Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study. Leukemia. 2021;35 (4):1121-1133. doi: 10.1038/s41375-020-01018-y. PubMed PMID:32814839 PubMed Central PMC7437386.
  194. Wang, Y, Du, G, Zhang, G, Matucci-Cerinic, M, Furst, DE. Similarities and differences between severe COVID-19 pneumonia and anti-MDA-5-positive dermatomyositis-associated rapidly progressive interstitial lung diseases: a challenge for the future. Ann Rheum Dis. 2022;81 (10):e192. doi: 10.1136/annrheumdis-2020-218594. PubMed PMID:32759260 .
  195. Burmester, GR, Buttgereit, F, Bernasconi, C, Álvaro-Gracia, JM, Castro, N, Dougados, M et al.. Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial. Lancet. 2020;396 (10246):267-276. doi: 10.1016/S0140-6736(20)30636-X. PubMed PMID:32711802 .
  196. Avanoǧlu Güler, A, Rossi, FW, Bellando-Randone, S, Prevete, N, Tufan, A, Manetti, M et al.. The Role of Endogenous Eicosapentaenoic Acid and Docosahexaenoic Acid-Derived Resolvins in Systemic Sclerosis. Front Immunol. 2020;11 :1249. doi: 10.3389/fimmu.2020.01249. PubMed PMID:32636845 PubMed Central PMC7318896.
  197. Occhipinti, M, Bruni, C, Camiciottoli, G, Bartolucci, M, Bellando-Randone, S, Bassetto, A et al.. Quantitative analysis of pulmonary vasculature in systemic sclerosis at spirometry-gated chest CT. Ann Rheum Dis. 2020;79 (9):1210-1217. doi: 10.1136/annrheumdis-2020-217359. PubMed PMID:32606043 .
  198. Bruni, C, De Luca, G, Lazzaroni, MG, Zanatta, E, Lepri, G, Airò, P et al.. Screening for pulmonary arterial hypertension in systemic sclerosis: A systematic literature review. Eur J Intern Med. 2020;78 :17-25. doi: 10.1016/j.ejim.2020.05.042. PubMed PMID:32540411 .
  199. Fioretto, BS, Rosa, I, Romano, E, Wang, Y, Guiducci, S, Zhang, G et al.. The contribution of epigenetics to the pathogenesis and gender dimorphism of systemic sclerosis: a comprehensive overview. Ther Adv Musculoskelet Dis. 2020;12 :1759720X20918456. doi: 10.1177/1759720X20918456. PubMed PMID:32523636 PubMed Central PMC7236401.
  200. Bruni, C, Bitti, R, Nacci, F, Cometi, L, Tofani, L, Bartoli, F et al.. Efficacy and safety of switching from reference adalimumab to SB5 in a real-life cohort of inflammatory rheumatic joint diseases. Clin Rheumatol. 2021;40 (1):85-91. doi: 10.1007/s10067-020-05199-w. PubMed PMID:32514676 .
Search PubMed